The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients.
P F
PF
Yumuk
S Z
SZ
Aydin
F
F
Dane
M
M
Gumus
M
M
Ekenel
M
M
Aliustaoglu
A
A
Karamanoglu
M
M
Sengoz
S N
SN
Turhal
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use*; D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use*; D002166:Camptothecin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003967:Diarrhea / Q000139:chemically induced* / Q000517:prevention & control*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D000077146:Irinotecan; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D009362:Neoplasm Metastasis
D000972:Antineoplastic Agents, Phytogenic; D018727:Muscarinic Antagonists; D000077146:Irinotecan; D001285:Atropine; D002166:Camptothecin